proto script ii reverse transcription kit (New England Biolabs)
New England Biolabs is a verified supplier 
New England Biolabs manufactures this product 
99
Structured Review
New England Biolabs
proto script ii reverse transcription kit
Proto Script Ii Reverse Transcription Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1832 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proto+script+ii+reverse+transcription+kit/ProtoScript+II+First+Strand+cDNA+Synthesis+Kit/us12612395-1489-17-23
Average 99 stars, based on 1832 article reviews
Proto Script Ii Reverse Transcription Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1832 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proto+script+ii+reverse+transcription+kit/ProtoScript+II+First+Strand+cDNA+Synthesis+Kit/us12612395-1489-17-23
Average 99 stars, based on 1832 article reviews
proto script ii reverse transcription kit - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Synthesized:Article Title: Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer. Article Snippet: .. The cDNA was synthesized using Article Title: Rocaglate derivatives and uses thereof Article Snippet: .. Quantitative RT-PCR: Total RNA was extracted from cells using Trizol (Invitrogen, Cat #15596). cDNA was synthesized using Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Article Snippet: For siRNA knockdown, 6 × 105 A673 cells, at 60% confluency and cultured in Opti-MEM ReducedSerum Medium (Gibco Cat# 31985-070), were transfected with the following siRNAs (obtained from Dharmacon (Colorado, USA)) at 100 nMusing Lipofectamine RNAiMAXTransfection Reagent: GLI1-1 (J003896-05-0005), GLI1-2 (L-003896-00-0005), GLI2-1 (A-006468-140005), GLI2-2 (A-006468-15-0005), SMO-1 (A-005726-13-0005), SMO2 (L-005726-00-0005), or a control pool (D-001810-10-05). .. Total RNAwas isolated fromcells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Article Title: Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells Article Snippet: .. Quantitative RT-PCR Total RNA was extracted from cells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Article Title: Inhibiting the GPI Transamidase Subunit GPAA1 Abolishes CD24 Surface Localization and Enhances Macrophage-Mediated Phagocytosis of Ovarian Cancer Cells Article Snippet: .. The cDNA was synthesized using Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: For siRNA knockdown, 6 × 10 5 A673 cells, at 60% confluency and cultured in Opti-MEM Reduced-Serum Medium (Gibco Cat# 31985-070), were transfected with the following siRNAs (obtained from Dharmacon (Colorado, USA)) at 100 nM using Lipofectamine RNAiMAX Transfection Reagent: GLI1-1 (J-003896-05-0005), GLI1-2 (L-003896-00-0005), GLI2-1 (A-006468-14-0005), GLI2-2 (A-006468-15-0005), SMO-1 (A-005726-13-0005), SMO-2 (L-005726-00-0005), or a control pool (D-001810-10-05). .. Total RNA was isolated from cells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Reverse Transcription:Article Title: Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer. Article Snippet: .. The cDNA was synthesized using Article Title: Rocaglate derivatives and uses thereof Article Snippet: .. Quantitative RT-PCR: Total RNA was extracted from cells using Trizol (Invitrogen, Cat #15596). cDNA was synthesized using Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Article Snippet: For siRNA knockdown, 6 × 105 A673 cells, at 60% confluency and cultured in Opti-MEM ReducedSerum Medium (Gibco Cat# 31985-070), were transfected with the following siRNAs (obtained from Dharmacon (Colorado, USA)) at 100 nMusing Lipofectamine RNAiMAXTransfection Reagent: GLI1-1 (J003896-05-0005), GLI1-2 (L-003896-00-0005), GLI2-1 (A-006468-140005), GLI2-2 (A-006468-15-0005), SMO-1 (A-005726-13-0005), SMO2 (L-005726-00-0005), or a control pool (D-001810-10-05). .. Total RNAwas isolated fromcells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Article Title: Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells Article Snippet: .. Quantitative RT-PCR Total RNA was extracted from cells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Article Title: Inhibiting the GPI Transamidase Subunit GPAA1 Abolishes CD24 Surface Localization and Enhances Macrophage-Mediated Phagocytosis of Ovarian Cancer Cells Article Snippet: .. The cDNA was synthesized using Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: For siRNA knockdown, 6 × 10 5 A673 cells, at 60% confluency and cultured in Opti-MEM Reduced-Serum Medium (Gibco Cat# 31985-070), were transfected with the following siRNAs (obtained from Dharmacon (Colorado, USA)) at 100 nM using Lipofectamine RNAiMAX Transfection Reagent: GLI1-1 (J-003896-05-0005), GLI1-2 (L-003896-00-0005), GLI2-1 (A-006468-14-0005), GLI2-2 (A-006468-15-0005), SMO-1 (A-005726-13-0005), SMO-2 (L-005726-00-0005), or a control pool (D-001810-10-05). .. Total RNA was isolated from cells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Real-time Polymerase Chain Reaction:Article Title: Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer. Article Snippet: .. The cDNA was synthesized using Article Title: Rocaglate derivatives and uses thereof Article Snippet: .. Quantitative RT-PCR: Total RNA was extracted from cells using Trizol (Invitrogen, Cat #15596). cDNA was synthesized using Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Article Snippet: For siRNA knockdown, 6 × 105 A673 cells, at 60% confluency and cultured in Opti-MEM ReducedSerum Medium (Gibco Cat# 31985-070), were transfected with the following siRNAs (obtained from Dharmacon (Colorado, USA)) at 100 nMusing Lipofectamine RNAiMAXTransfection Reagent: GLI1-1 (J003896-05-0005), GLI1-2 (L-003896-00-0005), GLI2-1 (A-006468-140005), GLI2-2 (A-006468-15-0005), SMO-1 (A-005726-13-0005), SMO2 (L-005726-00-0005), or a control pool (D-001810-10-05). .. Total RNAwas isolated fromcells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Article Title: Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells Article Snippet: .. Quantitative RT-PCR Total RNA was extracted from cells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Article Title: Inhibiting the GPI Transamidase Subunit GPAA1 Abolishes CD24 Surface Localization and Enhances Macrophage-Mediated Phagocytosis of Ovarian Cancer Cells Article Snippet: .. The cDNA was synthesized using Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: For siRNA knockdown, 6 × 10 5 A673 cells, at 60% confluency and cultured in Opti-MEM Reduced-Serum Medium (Gibco Cat# 31985-070), were transfected with the following siRNAs (obtained from Dharmacon (Colorado, USA)) at 100 nM using Lipofectamine RNAiMAX Transfection Reagent: GLI1-1 (J-003896-05-0005), GLI1-2 (L-003896-00-0005), GLI2-1 (A-006468-14-0005), GLI2-2 (A-006468-15-0005), SMO-1 (A-005726-13-0005), SMO-2 (L-005726-00-0005), or a control pool (D-001810-10-05). .. Total RNA was isolated from cells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Quantitative RT-PCR:Article Title: Rocaglate derivatives and uses thereof Article Snippet: .. Quantitative RT-PCR: Total RNA was extracted from cells using Trizol (Invitrogen, Cat #15596). cDNA was synthesized using Article Title: Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells Article Snippet: .. Quantitative RT-PCR Total RNA was extracted from cells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Isolation:Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Article Snippet: For siRNA knockdown, 6 × 105 A673 cells, at 60% confluency and cultured in Opti-MEM ReducedSerum Medium (Gibco Cat# 31985-070), were transfected with the following siRNAs (obtained from Dharmacon (Colorado, USA)) at 100 nMusing Lipofectamine RNAiMAXTransfection Reagent: GLI1-1 (J003896-05-0005), GLI1-2 (L-003896-00-0005), GLI2-1 (A-006468-140005), GLI2-2 (A-006468-15-0005), SMO-1 (A-005726-13-0005), SMO2 (L-005726-00-0005), or a control pool (D-001810-10-05). .. Total RNAwas isolated fromcells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using Article Title: The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma Article Snippet: For siRNA knockdown, 6 × 10 5 A673 cells, at 60% confluency and cultured in Opti-MEM Reduced-Serum Medium (Gibco Cat# 31985-070), were transfected with the following siRNAs (obtained from Dharmacon (Colorado, USA)) at 100 nM using Lipofectamine RNAiMAX Transfection Reagent: GLI1-1 (J-003896-05-0005), GLI1-2 (L-003896-00-0005), GLI2-1 (A-006468-14-0005), GLI2-2 (A-006468-15-0005), SMO-1 (A-005726-13-0005), SMO-2 (L-005726-00-0005), or a control pool (D-001810-10-05). .. Total RNA was isolated from cells using Trizol (Invitrogen, Cat# 15596). cDNA was synthesized using |